Vas Narasimhan, Novartis CEO (Photographer: Jason Alden/Bloomberg via Getty Images)
Novartis fails to win appeal in whistleblower case involving cancer drug study
A state ruling was handed down to Novartis on Monday, and not in the Big Pharma’s favor.
The ruling from New Jersey’s Superior Court, Appellate …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
